Phentermine Resin

Product NDC: 0527-1398
11-digit product format: 005271398
Labeler code: 0527
Product ID: 0527-1398_7bbef403-d696-4690-a1b1-8fd2d48eb52e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Phentermine Resin
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Lannett Company, Inc.
Application: ANDA040872
Marketing category: ANDA
Marketing start: 2011-07-28
Marketing end: 0000-00-00
Substance: PHENTERMINE
Active strength: 15 mg/1
Pharmacologic classes: Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0527-1398		D	Discontinued by firm		2026-08-17
excluded package	package	0527-1398	0527-1398-01	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0527-1398-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0527-1398-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0527-1398-01	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0527-1398-01	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0527-1398-01	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0527-1398-01	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0527-1398-01	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0527-1398-01	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0527-1398-01	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0527-1398-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0527-1398-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0527-1398-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	0527-1398-01	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	0527-1398-01	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	0527-1398-01	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	0527-1398-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	0527-1398-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	0527-1398-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	0527-1398-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	0527-1398-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	0527-1398-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040872-001	PHENTERMINE RESIN COMPLEX	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL			2011-07-28
A040872-002	PHENTERMINE RESIN COMPLEX	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL			2011-07-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040872-001	PHENTERMINE RESIN COMPLEX	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A040872-002	PHENTERMINE RESIN COMPLEX	EQ 30MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2011-07-28	`bb7c543d1eb4…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0527-1398-01	2024-12-12	C162847	48780-1	9d75b9d1-066f-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use phentermine resin extended-release capsules safely and effectively. See full prescribing information for phentermine resin extended-release capsules . PHENTERMINE Resin Extended-Release Capsules CIV Initial U.S. Approval: 1959
0527-1398-01	2020-01-31	C162847	48780-1	9d75b9d1-066f-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use phentermine resin extended-release capsules safely and effectively. See full prescribing information for phentermine resin extended-release capsules . PHENTERMINE Resin Extended-Release Capsules CIV Initial U.S. Approval: 1959

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PHENTERMINE	ACTIVE INGREDIENT	C045TQL4WP	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
PHENTERMINE	ACTIVE MOIETY	C045TQL4WP	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
BUTYL ALCOHOL	INACTIVE INGREDIENT	8PJ61P6TS3	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
GELATIN	INACTIVE INGREDIENT	2G86QN327L	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
METHYL ALCOHOL	INACTIVE INGREDIENT	Y4S76JWI15	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
SHELLAC	INACTIVE INGREDIENT	46N107B71O	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	9